Real-time enrollment status for this colorectal neoplasms clinical trial
Current Status
Recruiting
Checked: August 27, 2026 at 4:37 PM UTC
| NCT Number | NCT06131840 |
| Recruiting Status | Recruiting |
| Condition | Colorectal Neoplasms |
| Phase | PHASE1 |
| Target Enrollment | 914 participants |
| Active Locations | 21 sites in the US |
| Sponsor | Seagen, a wholly owned subsidiary of Pfizer |
| Last Updated on CT.gov | July 22, 2026 (Jul 22, 2026) |
As of August 27, 2026: Clinical trial NCT06131840 is currently recruiting participants. This phase1 study for colorectal neoplasms is actively seeking new participants at 21 locations across the United States. The study is sponsored by Seagen, a wholly owned subsidiary of Pfizer. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06131840 is actively recruiting participants as of August 27, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 21 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06131840 was last updated Jul 22, 2026 (July 22, 2026). HelloStudys verifies this status automatically.